Tech Transfer

COMMERCIALIZATION

An important goal of many of our programs in biomedical research is large-scale deployment of resultant technologies and/or knowledge for broader societal benefit. Our commercialization strategies rely on lean startup companies and/or joint development agreements, with a focus on engineering excellence and product deployments.

Partnerships
Intellectual Property

Partnerships

OpenClose

QSI-TEAMS is highly collaborative organization that is always open to forming new partnerships with industry and philanthropic organizations.

If you are interested in exploring opportunities with the group, please reach for more information.

Corporate Engagement John Rogers

Intellectual Property

OpenClose

If you are interested in any of the group’s intellectual property, please reach out for more information.

INVO John Rogers

STARTUP COMPANIES

Epicore Biosystems

Epicore has developed a proprietary soft and wearable microfluidics platform that is ‘skin-like’, low-cost, and capable of analyzing sweat composition and physiological metrics, non-invasively, for remote management of performance, wellness, and health biomarkers. Founded in 2017 as a spinout company from Northwestern’s Center for Bio-Integrated Electronics, Epicore has partnered with Fortune 500 companies, the Department of Defense, and leading research institutions to commercialize its wearable microfluidic products.

Neurolux, Inc.

NeuroLux developed a novel, turnkey wireless platform enabling fully implantable, wireless, battery free devices for optogenetics. Founded in 2016 as a spinout company from Northwestern’s Center for Bio-Integrated Electronics, NeuroLux has become a standard in the Neuroscience community with the only commercially available fully implantable battery free devices on the market and is now being used at more than 100 institutions worldwide.

Rhaeos

Rhaeos developed FlowSense, a noninvasive wearable platform technology initially targeting hydrocephalus, a life-threatening condition caused by an abnormal accumulation of cerebrospinal fluid in the brain that affects over 1M Americans today. Founded in 2018 as a spinout company from Northwestern’s Center for Bio-Integrated Electronics, Rhaeos aims to address a critical, unmet need through FlowSense, which follows a FDA De Novo 510(K) regulatory path on track for market entry in 2021.

Sibel Health

Sibel Health has developed the world's first ICU-grade wearable sensor system for measuring all core vital signs in any patient - from premature neonates to older adults. Founded in 2018 as a spinout of the Center for Bio-Integrated Electronics, Sibel has went on to develop partnerships with some of the world's most respected philanthropies, pharmaceutical companies, medical technology companies, and payers. Their core product - the ANNE One Platform - has reached thousands of lives in more than a dozen countries.

Wearifi

Wearifi develops mm-scale devices that can easily integrate into our daily lives with all of the performance of the current state of the art technology, at a fraction of the size, some even battery free. Founded in 2016 as a spinout company from Northwestern’s Center for Bio-Integrated Electronics, Wearifi’s unique patented technologies allow the development of the world’s smallest wearable wireless devices - small enough to fit on your fingernail.